Practice parameter: Diagnosis of dementia (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology

DS Knopman, ST DeKosky, JL Cummings, H Chui… - Neurology, 2001 - AAN Enterprises
Objective: To update the 1994 practice parameter for the diagnosis of dementia in the
elderly. Background: The AAN previously published a practice parameter on dementia in …

Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease: FDG-PET studies in MCI and AD

L Mosconi - European journal of nuclear medicine and molecular …, 2005 - Springer
The demographics of aging suggest a great need for the early diagnosis of dementia and
the development of preventive strategies. Neuropathology and structural MRI studies have …

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET

K Herholz, E Salmon, D Perani, JC Baron, V Holthoff… - Neuroimage, 2002 - Elsevier
A new diagnostic indicator of FDG PET scan abnormality, based on age-adjusted t statistics
and an automated voxel-based procedure, is presented and validated in a large data set …

Assessment of cerebral blood flow in Alzheimer's disease by spin‐labeled magnetic resonance imaging

DC Alsop, JA Detre, M Grossman - Annals of neurology, 2000 - Wiley Online Library
To evaluate the utility of arterial spin‐labeled blood flow magnetic resonance imaging for the
detection of cerebral blood flow abnormalities in Alzheimer's disease, arterial spin‐labeled …

Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer's disease

LM Bloudek, DE Spackman… - Journal of …, 2011 - content.iospress.com
Mild Alzheimer's disease (AD) is often difficult to differentiate from mild cognitive impairment
(MCI) or non-AD dementias. A multitude of diagnostic biomarkers and advanced imaging …

Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging

DHS Silverman - Journal of Nuclear Medicine, 2004 - Soc Nuclear Med
The clinical identification and differential diagnosis of dementias is especially challenging in
the early stages, but the need for early, accurate diagnosis has become more important, now …

Positron emission tomography imaging in dementia

K Herholz, SF Carter, M Jones - The British journal of radiology, 2007 - birpublications.org
Positron emission tomography (PET) is a well-established imaging modality. Measurement
of regional cerebral glucose metabolism (rCMRglc) using PET and [18F]-2-fluoro-2-deoxy-d …

Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging

N Schuff, S Matsumoto, J Kmiecik, C Studholme… - Alzheimer's & …, 2009 - Elsevier
BACKGROUND: Our objectives were to compare the effects of subcortical ischemic vascular
dementia (SIVD) and Alzheimer's disease (AD) on cerebral blood flow (CBF), and then to …

[HTML][HTML] Mitophagy and the brain

NS Swerdlow, HM Wilkins - International journal of molecular sciences, 2020 - mdpi.com
Stress mechanisms have long been associated with neuronal loss and neurodegenerative
diseases. The origin of cell stress and neuronal loss likely stems from multiple pathways …

PET studies in dementia

K Herholz - Annals of nuclear medicine, 2003 - Springer
Measurement of local cerebral glucose metabolism (lCMRGlc) by positron emission
tomography (PET) and 18 F-2-fluoro-2-deoxy-d-glucose (FDG) has become a standard …